A Phase 1 Safety and Tolerability Study of Intralesional PV-10 Chemoablation in Subjects With Metastatic Melanoma

Trial Profile

A Phase 1 Safety and Tolerability Study of Intralesional PV-10 Chemoablation in Subjects With Metastatic Melanoma

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Dec 2008

At a glance

  • Drugs Rose bengal sodium (Primary)
  • Indications Malignant melanoma
  • Focus Adverse reactions
  • Sponsors Provectus Pharmaceuticals
  • Most Recent Events

    • 01 Dec 2008 A peer-reviewed paper based on Phase 1 study findings was published in the December 2008 edition of Melanoma Research.
    • 19 Nov 2008 Updated long-term survival data were presented at the Clinical Oncological Society of Australia.
    • 15 Oct 2008 Results published in the December 2008 issue of Melanoma Research.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top